Stockreport

SAB BIO Reports Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF and on track to complete enrollment by end of 2026 with topline data expected in 2H 2027 Reported Phase 1 clinical data, including healthy volunteer, redosing, and T1D [Read more]